Mindstate Design Labs develops a neurotech AI platform for psychedelic drug development, focusing on precision design of altered states of consciousness.
Employees
7
Founded
2021
Revenue
$1.3M
Company Stage
Seed
YC Batch
S21
Product Features & Capabilities
Neurotech AI platform, target discovery platform (Osmanthus), phenotypic screening, precision design of modified conscious states, psychedelic primer and probe compounds, therapeutic utility candidates.